Tata Capital Unlisted Shares
Tata Capital PE plans to invest over Rs 400 cr in healthcare, senior care
Business Standard
2 min read
Tata Capital Healthcare Fund (TCHF) plans to invest over Rs 400 crore ($50 million)
Expert Analysis:
TCHF plans to invest Rs.400cr in the healthcare & life science sector for the next 9-12 months.
The investment would be made from the second fund (TCHF II) (corpus available:$130 million.)
Visalakshi Chandramouli, TCHF's managing partner, stated the fund invested 60% in various segments.
In 2023, TCHF invested up to $10 million infusion in Apex Kidney Care (AKC).
Impact Of Investments: Over the last year, the fund has seen a 46.7% rise in jobs and a 7% increase in beneficiaries, accounting for more than 9.5 million.
Growth-Oriented: TCHF, a private equity fund, raised almost $200 million through TCHF I (2012) and TCHF II (2022), investing in 16 companies and successfully exiting 6.
Long-term plan: Investing in Apex Kidney Care and Mumbai Oncocare Centre, both major players in India's vast healthcare sector, is poised to yield a significant and positive long-term impact.
Precize Daily Pulse
The latest news in the world of Unlisted Shares, summarised by our experts.
Company
Our Office
Office No. 1219, The Summit Business Park, Andheri Kurla Road, Andheri East, Mumbai, Maharashtra - 400093
Find us on Googlesupport@precize.in
+91 7738336457
All trademarks and logos or registered trademarks and logos found on this Site or mentioned herein belong to their respective owners and are solely used for informational and educational purposes.
The material presented in this advertisement is for informational purposes only and should not be construed as investment advice or investment availability. It is not a recommendation of, or an offer to sell or solicitation of an offer to buy, any particular unlisted share, security, strategy, or investment product. Investing in the private market and securities involves risks, including the potential loss of money, and past performance does not guarantee future results. Market trends, data interpretations, graph projections are provided for informational and illustrative purposes and may not reflect actual future performance. Nothing on this website should be construed as personalized investment advice or should not be treated as legal, financial, or any other form of advice. Precize is not liable for financial or any other form of loss incurred by the user or any affiliated party based on information provided herein.
Precize is neither a stock exchange nor does it intend to get recognized as a stock exchange under the Securities Contracts Regulation Act, 1956. Precize is not authorized by the capital markets regulator to solicit investments. The securities traded on these platforms are not traded on any regulated exchange.
The website will be updated regularly.
Copyright © 2026 - Precize - All Rights Reserved